Estimand framework and intercurrent events handling for clinical trials with time-to-event outcomes
By: Yixin Fang, Man Jin
Potential Business Impact:
Helps doctors test new medicines better.
The ICH E9(R1) guideline presents a framework of estimand for clinical trials, proposes five strategies for handling intercurrent events (ICEs), and provides a comprehensive discussion and many real-life clinical examples for quantitative outcomes and categorical outcomes. However, in ICH E9(R1) the discussion is lacking for time-to-event (TTE) outcomes. In this paper, we discuss how to define estimands and how to handle ICEs for clinical trials with TTE outcomes. Specifically, we discuss six ICE handling strategies, including those five strategies proposed by ICH E9(R1) and a new strategy, the competing-risk strategy. Compared with ICH E9(R1), the novelty of this paper is three-fold: (1) the estimands are defined in terms of potential outcomes, (2) the methods can utilize time-dependent covariates straightforwardly, and (3) the efficient estimators are discussed accordingly.
Similar Papers
Estimating treatment effects with competing intercurrent events in randomized controlled trials
Methodology
Fixes drug study results when things change.
Incorporating estimands into meta-analyses of clinical trials
Applications
Helps doctors combine study results better.
The role of post intercurrent event data in the estimation of hypothetical estimands in clinical trials
Methodology
Uses patient data after sickness to improve medicine tests.